Rising Prevalence Of Blood Clotting Or Bleeding Disorders And Rapid Rate Of Adoption Of Automated Hemostasis Equipment In Diagnostic Laboratories To Boost The Market

According to a recently published report, the global Hemostasis Analyzers Market is expected to grow around $4,500millionby 2022with an impressive CAGR of 9.7% during 2016-2022. The segmentation of global hemostasis analyzers market is based ontype of test, technology, end users, product type,andregional outlook. The report on global hemostasis analyzers market forecast 2016-2022 (by type of test, technology, end users, product type,andregional outlook) provides a detailed overview and predictive analysis of the market.

Full report available global hemostasis analyzers market forecast2016-2022 (by type of test, technology, end user, product type,and regional outlook)report at http://www.briskinsights.com/report/hemostasis-analyzers-market

Continuous innovation in technology has led to the introduction of many new diagnostics and therapeutic devicessuch as high throughput hemostasis analyzers that is anticipated to boost the global hemostasis analyzers market growth over the forecast period. Apart from that, growing prevalence of chronic diseases coupled with rising incidences of blood clotting and other bleeding disorders are expected to fuel the growth of the global hemostasis analyzers market. Hemostasis analyzers are components which helps in thwarting excess blood loss during surgeries by changing the liquid blood into gel. Growth of high throughput hemostasis analyzers are predictable to result in revolutionary changes in hemostasis analyzers market over the forecast time period. Technological advancement,growing geriatric population base,and growing adoption of automated hemostasis instruments are the major factors boosting the growth of this market. North American region is expected to dominate the global hemostasis analyzers market during the forecast period. The rising R&D activities; developed healthcare infrastructure;and, rising incidences of surgeries & organ transplant procedures are some factors expected to help this region to maintain its dominance on the global market over the forecast period.

Scope of the Report

1. Global Hemostasis Analyzers Market by Type of Test 2012-2022 ($ Million)
1.1. Prothrombin Time (PT/INR) Testing Kits
1.2. Activated Clotting Time (ACT/APTT) Testing Kits
1.3. D Dimer Testing Kits
1.4. Fibrinogen Testing Kits
1.5. Others Testing Kits

2. Global Hemostasis Analyzers Market by Technology 2012-2022 ($ Million)
2.1. Mechanical
2.2. Optical
2.3. Electrochemical
2.4. others

3. Global Hemostasis Analyzers Market by End User 2012-2022 ($ Million)
3.1. Research Institutes
3.2. Diagnostic Laboratories
3.3. Standalone Hospitals
3.4. others end users

4. Global Hemostasis Analyzers Market by Product Type 2012-2022 ($ Million)
4.1. Clinical Laboratory Analyzers
4.1.1. HemostasisAnalyzers
4.1.1.1. Automated Hemostasis Analyzers
4.1.1.2. Semi-Automated Hemostasis Analyzers
4.1.1.3. Manual Hemostasis Analyzers
4.2. Consumables
4.2.1. Reagents
4.2.2. Standards, Controls and Calibrations
4.3. Hemostasis Analyzers for Point-Of-Care Testing

5. Global Hemostasis Analyzers Market Regional Outlook 2012-2022 ($ Million)
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Rest of the world

6. Company Profiles
6.1. Alere, Inc.
6.2. Beckman Coulter
6.3. Becton Dickinson
6.4. DiagnosticaStago, Inc.
6.5. Helena Laboratories
6.6. Horiba
6.7. Instrumentation Laboratory Werfen Group
6.8. International Technidyne Corporation
6.9. Mindray
6.10. Nihon Kohden Corporation (Nihon Kohden)
6.11. Roche Diagnostics
6.12. Siemens Healthcare
6.13. Sysmex Corporation
6.14. Thermo Fisher Scientific, Inc.
6.15. Transasia Bio Medical Ltd.